The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ESMO Sarcoma & GIST 2022 | The advantages of face-to-face meetings

Name: The advantages of face-to-face meetings
Uploaded: 2022-02-09T00:00:00Z
Duration: 30 s
Description: Robin Jones, MBBS, MRCP, MD, talks on the advantages of face-to-face meetings as opposed to virtual. This interview took place during the European Society for Medical Oncology (ESMO) Sarcoma & GIST Symposium.

Robin Jones • 9 Feb 2022

ESMO Sarcoma & GIST 2022

Gastrointestinal Cancer Sarcoma

Robin Jones, MBBS, MRCP, MD, talks on the advantages of face-to-face meetings as opposed to virtual. This interview took place during the European Society for Medical Oncology (ESMO) Sarcoma & GIST Symposium.